Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-15

Clinical Trial Update: Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating thalidomide for chronic cough in idiopathic pulmonary fibrosis completed, with results posted in May 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thalidomide (thalidomide)

Snippet

Sponsor: Johns Hopkins University | Conditions: Idiopathic Pulmonary Fibrosis, Cough | Phase 3 | Status: COMPLETED | Results posted: 2017-05-15